Revenue: The sum of all revenue fields included for a company's operating activities.
Aligos Therapeutics, Inc. (ALGS) had Revenue of $27.78M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$27.78M |
$-1.50M |
|
-- |
|
$27.78M |
|
$29.67M |
|
$-1.89M |
|
$3.20M |
|
$1.31M |
|
$1.31M |
|
$-1.50M |
|
$-1.50M |
|
$-1.50M |
|
$-1.50M |
|
$-1.89M |
|
$-1.71M |
|
10.43M |
|
10.43M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$62.13M |
|
$1.33M |
|
$4.20M |
|
$66.33M |
|
$28.34M |
|
-- |
|
$6.10M |
|
$34.44M |
|
$31.88M |
|
$31.88M |
|
$31.88M |
|
6.24M |
|
| Cash Flow Statement Financials | |
$-48.08M |
|
$59.93M |
|
$0.16M |
|
$18.41M |
|
$30.42M |
|
$12.01M |
|
$2.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.19 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
100.00% |
|
-6.80% |
|
-6.80% |
|
-- |
|
4.71% |
|
-5.41% |
|
$-48.15M |
|
-- |
|
-- |
|
-- |
|
0.42 |
|
-- |
|
1.00 |
|
90.00 |
|
-4.72% |
|
-4.72% |
|
-2.27% |
|
-4.72% |
|
$5.11 |
|
$-4.62 |
|
$-4.61 |
|